| Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale P Martínez-Martín, C Rodríguez-Blázquez, M Alvarez, T Arakaki, VC Arillo, ... Parkinsonism & related disorders 21 (1), 50-54, 2015 | 310 | 2015 |
| Depression in classic versus akinetic‐rigid Parkinson's disease SE Starkstein, G Petracca, E Chemerinski, A Tesón, L Sabe, M Merello, ... Movement disorders: official journal of the Movement Disorder Society 13 (1 …, 1998 | 212 | 1998 |
| The nature of apraxia in corticobasal degeneration. R Leiguarda, AJ Lees, M Merello, S Starkstein, CD Marsden Journal of Neurology, Neurosurgery & Psychiatry 57 (4), 455-459, 1994 | 200 | 1994 |
| Effect of memantine (NMDA antagonist) on Parkinson's disease: a double-blind crossover randomized study M Merello, MI Nouzeilles, A Cammarota, R Leiguarda Clinical neuropharmacology 22 (5), 273-276, 1999 | 196 | 1999 |
| Catatonia in depression: prevalence, clinical correlates, and validation of a scale. SE Starkstein, G Petracca, A Teson, E Chemerinski, M Merello, ... Journal of Neurology, Neurosurgery & Psychiatry 60 (3), 326-332, 1996 | 184 | 1996 |
| Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism. RC Leiguarda, PP Pramstaller, M Merello, S Starkstein, AJ Lees, ... Brain: a journal of neurology 120 (1), 75-90, 1997 | 181 | 1997 |
| The syndromal validity and nosological position of apathy in Parkinson's disease SE Starkstein, M Merello, R Jorge, S Brockman, D Bruce, B Power Movement Disorders 24 (8), 1211-1216, 2009 | 171 | 2009 |
| Autosomal dominant cerebellar ataxias: a systematic review of clinical features M Rossi, S Perez‐Lloret, L Doldan, D Cerquetti, J Balej, P Millar Vernetti, ... European Journal of Neurology 21 (4), 607-615, 2014 | 152 | 2014 |
| Decision‐making in Parkinson’s disease patients with and without pathological gambling M Rossi, ER Gerschcovich, D De Achaval, S Perez‐Lloret, D Cerquetti, ... European Journal of Neurology 17 (1), 97-102, 2010 | 143 | 2010 |
| Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia. SE Starkstein, L Sabe, G Petracca, E Chemerinski, G Kuzis, M Merello, ... Journal of Neurology, Neurosurgery & Psychiatry 61 (4), 381-387, 1996 | 140 | 1996 |
| Management of advanced therapies in Parkinson's disease patients in times of humanitarian crisis: the COVID‐19 experience A Fasano, A Antonini, R Katzenschlager, P Krack, P Odin, AH Evans, ... Movement disorders clinical practice 7 (4), 361-372, 2020 | 138 | 2020 |
| A validation study of depressive syndromes in Parkinson's disease SE Starkstein, M Merello, R Jorge, S Brockman, D Bruce, G Petracca, ... Movement disorders: official journal of the Movement Disorder Society 23 (4 …, 2008 | 138 | 2008 |
| Unilateral radiofrequency lesion versus electrostimulation of posteroventral pallidum: a prospective randomized comparison M Merello, MI Nouzeilles, G Kuzis, A Cammarota, L Sabe, O Betti, ... Movement disorders: official journal of the Movement Disorder Society 14 (1 …, 1999 | 134 | 1999 |
| Wearing‐off scales in Parkinson's disease: critique and recommendations A Antonini, P Martinez‐Martin, RK Chaudhuri, M Merello, R Hauser, ... Movement Disorders 26 (12), 2169-2175, 2011 | 128 | 2011 |
| Apomorphine induces changes in GPi spontaneous outflow in patients with Parkinson's disease M Merello, J Balej, M Delfino, A Cammarota, O Betti, R Leiguarda Movement disorders: official journal of the Movement Disorder Society 14 (1 …, 1999 | 125 | 1999 |
| Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations C Colosimo, P Martínez‐Martín, G Fabbrini, RA Hauser, M Merello, ... Movement Disorders 25 (9), 1131-1142, 2010 | 122 | 2010 |
| Addenbrooke’s Cognitive Examination validation in Parkinson’s disease MA Reyes, SP Lloret, ER Gerscovich, ME Martin, R Leiguarda, M Merello European Journal of Neurology 16 (1), 142-147, 2009 | 122 | 2009 |
| Accuracy of acute levodopa challenge for clinical prediction of sustained long‐term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis M Merello, MI Nouzeilles, GP Arce, R Leiguarda Movement disorders 17 (4), 795-798, 2002 | 121 | 2002 |
| SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy M Merello, KP Bhatia, JA Obeso The Lancet Neurology 20 (2), 94-95, 2021 | 119 | 2021 |
| Effect of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, on the motor response to acute treatment with levodopa in patients with Parkinson's disease. M Merello, AJ Lees, R Webster, M Bovingdon, A Gordin Journal of Neurology, Neurosurgery & Psychiatry 57 (2), 186-189, 1994 | 117 | 1994 |
Malco RossiFLENI - CONICETVerified email at fleni.org.ar
